New research suggests that oral drugs for erectile dysfunction (ED) don’t increase a man’s risk for biochemical recurrence of prostate cancer.
The term “biochemical recurrence” refers to the possibility that prostate cancer has come back after treatment. This occurs when a PSA (prostate-specific antigen) test shows that PSA levels have increased. Elevated PSA levels are not always a sign of...
All News
After treatment for gynecologic cancer, women have sex less frequently, according scientists from...
When a man has surgery for prostate cancer, it can affect sex for both him and his partner, Swiss...
Testosterone levels don’t appear to affect the severity of Peyronie’s disease, according to...